Do you identify as Hispanic, Latino, and/or from Latin America? Are you an adult? If so, you may be able to participate in a study about your identity in the United States. I would love to hear about your experiences.

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AK117 to patients with Leukemia

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.

Have you been diagnosed with s Cutaneous (skin) Lymphoma? If so this could be a good study for you to paticipate in. One of the primary goals of the USCLC is to establish a registry of patients with cutaneous lymphoma in the United States. Such a registry would collect information such as the specific cutaneous lymphoma diagnosis, stage of disease, treatments used, and response to treatments. This information will collected on an online Institutional Review Board (IRB)-approved database/registry of patients from all sites. We hope that this will allow providers to better understand this rare disease by looking at data from many patients. We hope ultimately will include all the patients with cutaneous lymphoma across the United States

If you have NMOSD, you are between the ages of 18 and 60, and you use a smart phone, you may be able to participate in a clinical trial testing a new self-assessment tool app. Compensation provided.

Are you an adult under the age of 59 years? Do you sit too much and want to learn more about how sitting impacts the stiffness of your blood vessels? If so, you may be able to participate in a study to see how the position of your legs affects your arteries after sitting for a long time. Compensation provided.

Have you been histologically or cytologically confirmed to have Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma that is considered incurable by local therapies? If so, you may be able to participate in a research study seeking to find out if Amivantamab Monotherapy and/or Amivantamab in Addition to Standard of Care Therapeutic Agents can be an effective traetment.

Are you an adult between the ages of 18 and 35? Are you interested in brain research? If so, you may be able to participate in a study to see how people see social interactions in different situations. Compensation provided.

Have you been diagnosed with Chronic Myeloid Leukemia, have a T315I mutation, and previously treated with at least two tyrosine kinase inhibitors (TKIs)? You might be able to participate in this study.